Hem/Onc News

Tagraxofusp-erzs Approved in Blastic Plasmacytoid Dendritic Cell Neoplasm  The US Food and Drug Administration (FDA) approved tagraxofusp-erzs (Elzonris, Stemline) on December 21 for blastic plasmacytoid dendritic […]